SDC2 and colonic neoplasm: Although future studies will be required to fully elucidate the mechanisms through which syndecan-2-induced MMP-7-mediated signaling affects colon cancer cells, our present findings provide important new insights into the regulation of colon cancer mediated by syndecan-2 as a docking receptor at the cancer cell surface.